s20098 has been researched along with Panic Disorder in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uvais, NA | 1 |
| Deuschle, M; Fischer, EC; Zapp, AA | 1 |
| Batelaan, NM; Huijbregts, KM; Schonenberg, J; van Balkom, AJ; Veen, G | 1 |
| Freire, RC; Levitan, MN; Mochcovitch, M; Nardi, AE; Papelbaum, M; Simões, P; Soares, G; Zugliani, M | 1 |
| Fornaro, M | 1 |
1 trial(s) available for s20098 and Panic Disorder
| Article | Year |
|---|---|
Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trial.
Topics: Acetamides; Anti-Anxiety Agents; Female; Humans; Male; Middle Aged; Panic Disorder | 2015 |
4 other study(ies) available for s20098 and Panic Disorder
| Article | Year |
|---|---|
Psychological Impact of the COVID-19 Pandemic Among the Elderly: A Case Series From India.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents; Betacoronavirus; Citalopram; Clonazepam; Coronavirus Infections; COVID-19; Depressive Disorder; Female; Humans; India; Lorazepam; Male; Mirtazapine; Pandemics; Panic Disorder; Pneumonia, Viral; SARS-CoV-2 | 2020 |
The effect of agomelatine and melatonin on sleep-related eating: a case report.
Topics: Acetamides; Central Nervous System Depressants; Depressive Disorder, Major; Female; Humans; Melatonin; Middle Aged; Night Eating Syndrome; Panic Disorder; Patient Compliance; Sleep Wake Disorders; Treatment Outcome; Weight Gain | 2017 |
Agomelatine in Panic Disorder: A 6-Week Follow-Up Case Series.
Topics: Acetamides; Adult; Antidepressive Agents; Female; Follow-Up Studies; Humans; Male; Panic Disorder; Treatment Outcome | 2016 |
Agomelatine in the treatment of panic disorder.
Topics: Acetamides; Humans; Hypnotics and Sedatives; Male; Panic Disorder; Young Adult | 2011 |